{"id":"W2046705215","doi":"10.1158/0008-5472.sabcs-903","title":"Bevacizumab (BV) maintenance therapy significantly delays disease progression (PD) or death compared with placebo (PL) in the AVADO trial (BV + docetaxel [D] vs D + PL in 1st-line HER2-negative locally recurrent [LR] or metastatic breast cancer [mBC]).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Discontinuation; Concomitant; Docetaxel; Taxane; Chemotherapy; Oncology; Gastroenterology; Cancer; Urology; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009380432,0.0004812543,0.0009273527,0.0001434073,0.0001005851,0.0005391979,0.0004077676,0.0005270395,0.003189337],"category_scores_gemma":[0.001161782,0.0002433874,0.0008664317,0.0001498584,0.0003417939,0.0003956604,0.00020747,0.001497958,0.0002388599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003877769,"about_ca_system_score_gemma":0.0004602649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007676142,"about_ca_topic_score_gemma":0.002243509,"domain_scores_codex":[0.9996498,0.0002070433,0.00001995082,0.00005683292,0.00002272522,0.00004370729],"domain_scores_gemma":[0.9992372,0.0003031718,0.000198366,0.00004537291,0.00002041942,0.0001956217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9127336,0.006208979,0.002434038,0.0006860856,0.0008443518,0.00003815798,0.00008968106,0.0007222433,0.01748401,0.0001596573,0.001116883,0.0574825],"study_design_scores_gemma":[0.4688101,0.4986428,0.02244136,0.0001200744,0.001321588,0.0001352344,0.00007399618,0.001479076,0.004170639,0.0002365226,0.002540918,0.00002762341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949464,0.002557033,0.0002133639,0.0001790061,0.00009594364,0.0002715948,0.0003974628,0.00003155656,0.001307685],"genre_scores_gemma":[0.9963602,0.001202862,0.0003796726,0.0001458376,0.00008018425,0.0002341336,0.0004033719,0.000008511917,0.001185179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003189337,"threshold_uncertainty_score":0.01066935,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.163774819216005,"score_gpt":0.477930570792345,"score_spread":0.31415575157634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}